Update on the diagnosis and management of acute heart failure.

Link to article at PubMed

Related Articles

Update on the diagnosis and management of acute heart failure.

Curr Opin Cardiol. 2018 Dec 12;:

Authors: Gouda P, Ezekowitz JA

Abstract
PURPOSE OF REVIEW: To highlight the advances in the diagnosis and management of acute heart failure (AHF) from recent clinical trials and observational studies.
RECENT FINDINGS: We highlight date from recent studies examining the use of novel biomarkers (micro RNAs, osteopontin, insulin-like growth-factor binding protein-7) for the diagnosis of AHF. In addition, we summarize the evidence for novel pharmacological therapies including: serelaxin, ularitide, clevidipine, urocortins, BMS-986231, TRB027, vericiguat, omecamtiv, and torsemide. Finally, we explore the evidence behind the use of novel management algorithms.
SUMMARY: Despite many advances in understanding the pathophysiology of AHF, there is currently insufficient evidence to suggest changes to standards of care.

PMID: 30547895 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *